OpenNational Institutes of Health

Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)

Opportunity number PAR-25-282 · Assistance listing 93.313, 93.242

Deadline
Jan 7, 2028 · 435 days left
Posted
Nov 22, 2024
Award size
Not listed
Total program funding
Not listed
Expected awards
Not listed
Cost sharing
Not required
Funding type
Grant
Category
Health
NIH R21: recently funded projects, typical award sizes and top institutions

Check this solicitation free

Grantee reads the full announcement and lists every required section, page limit, deadline, scoring criterion and compliance item. Takes about two minutes, no account needed.

About this opportunity

The purpose of this Notice of Funding Opportunity (NOFO) is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal depression (PMD), generalized anxiety disorder, bipolar disorder and schizophrenia) during the menopause transition (MT) in an effort to identity targets for future development of novel treatment interventions. This funding opportunity aims to advance novel and innovative translational research to better comprehend the underlying neurobiological and behavioral mechanisms of mood and psychosis disorders and related symptoms during MT. This funding opportunity also encourages interdisciplinary researchers to collaborate on studies of mood and psychosis during the MT. Aspects of mood and psychosis disorders that are of interest include: classic depressive symptoms in combination with menopause symptoms (e.g., hot flashes, night sweats, sleep disturbance) and psychological challenges, the role of reproductive steroids in the regulation of mood and behavior during the MT, diagnosis of mood and psychosis symptoms at menopausal stage, investigation of co-occurring psychiatric and menopause symptoms, appreciation of psychosocial factors common in midlife, and differential diagnoses. Review criteria will focus on the comprehensiveness of the neurobiology and mechanisms of action underlying mood and psychosis symptoms and hypothesis-driven work.

Who can apply

  • Independent school districts
  • For-profit organizations
  • Other (see eligibility)
  • State governments
  • Nonprofits with 501(c)(3) status
  • Special district governments
  • Nonprofits without 501(c)(3) status
  • Private universities
  • Small businesses
  • Public and Indian housing authorities
  • Other Native American tribal organizations
  • County governments
  • City or township governments
  • Federally recognized tribal governments
  • Public and state universities

Other Eligible Applicants include the following:

Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Agency contact

NIH Grants Information

grantsinfo@nih.gov
Write this proposal with Grantee
  • Reads the full solicitation and lays out every required section
  • Drafts each section with you, in your words
  • Checks the draft against every requirement before you submit
Official notice on Grants.gov

How to write it

All guides

More from NIH

All NIH funding

Get new funding every Monday

New federal opportunities and upcoming deadlines for NIH and more, in one short email. Free, unsubscribe anytime.

Details from Grants.gov, last updated Nov 22, 2024. Deadlines and requirements can change: always confirm them in the official notice and the agency's page.